HEADER TRANSFERASE/TRANSFERASE INHIBITOR 10-JUN-19 6P9F TITLE CRYSTAL STRUCTURE OF RAR-RELATED ORPHAN RECEPTOR C (NHIS-RORGT(244- TITLE 2 487)-L6-SRC1(678-692)) IN COMPLEX WITH A PHENYL (3-PHENYLPYRROLIDIN- TITLE 3 3-YL)SULFONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA, NUCLEAR RECEPTOR COACTIVATOR 1 COMPND 3 CHIMERA; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: LIGAND-BINDING DOMAIN (UNP RESIDUES 265-508) FUSED TO SRC COMPND 6 PEPTIDE (UNP RESIDUES 683-696); COMPND 7 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 8 GROUP F MEMBER 3, RAR-RELATED ORPHAN RECEPTOR C, RETINOID-RELATED COMPND 9 ORPHAN RECEPTOR-GAMMA,NCOA-1, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN COMPND 10 74, BHLHE74, PROTEIN HIN-2, RIP160, RENAL CARCINOMA ANTIGEN NY-REN- COMPND 11 52,STEROID RECEPTOR COACTIVATOR 1, SRC-1; COMPND 12 EC: 2.3.1.48; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG, NCOA1, BHLHE74, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RORGT, NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVE AGONIST, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.SACK REVDAT 3 11-OCT-23 6P9F 1 REMARK REVDAT 2 28-AUG-19 6P9F 1 JRNL REVDAT 1 17-JUL-19 6P9F 0 JRNL AUTH Z.LU,J.J.DUAN,H.XIAO,J.NEELS,D.R.WU,C.A.WEIGELT,J.S.SACK, JRNL AUTH 2 J.KHAN,M.RUZANOV,Y.AN,M.YARDE,A.KARMAKAR,S.VISHWAKRISHNAN, JRNL AUTH 3 V.BARATAM,H.SHANKARAPPA,S.VANTERU,V.BABU,M.BASHA, JRNL AUTH 4 A.KUMAR GUPTA,S.KUMARAVEL,A.MATHUR,Q.ZHAO,L.M.SALTER-CID, JRNL AUTH 5 P.H.CARTER,T.G.MURALI DHAR JRNL TITL IDENTIFICATION OF POTENT, SELECTIVE AND ORALLY BIOAVAILABLE JRNL TITL 2 PHENYL ((R)-3-PHENYLPYRROLIDIN-3-YL)SULFONE ANALOGUES AS ROR JRNL TITL 3 GAMMA T INVERSE AGONISTS. JRNL REF BIOORG.MED.CHEM.LETT. V. 29 2265 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 31257087 JRNL DOI 10.1016/J.BMCL.2019.06.036 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 15806 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.290 REMARK 3 FREE R VALUE TEST SET COUNT : 836 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 41 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.83 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.50 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 386 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2289 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 368 REMARK 3 BIN R VALUE (WORKING SET) : 0.2278 REMARK 3 BIN FREE R VALUE : 0.2562 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.66 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 23 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 87.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.24220 REMARK 3 B22 (A**2) : -2.24220 REMARK 3 B33 (A**2) : 4.48430 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.310 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4358 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5895 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1571 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 761 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4358 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 539 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5004 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.60 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.91 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6P9F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1000242167. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5-6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15848 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 159.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 6O98 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-26% PEG3350, 0.2 M MAGNESIUM REMARK 280 CHLORIDE, 0.1 M BIS-TRIS PH 5.5-6.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.83300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.91650 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 119.74950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 244 REMARK 465 GLY A 245 REMARK 465 SER A 246 REMARK 465 SER A 247 REMARK 465 HIS A 248 REMARK 465 HIS A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 SER A 254 REMARK 465 SER A 255 REMARK 465 GLY A 256 REMARK 465 LEU A 257 REMARK 465 VAL A 258 REMARK 465 PRO A 259 REMARK 465 ARG A 260 REMARK 465 GLY A 261 REMARK 465 SER A 262 REMARK 465 HIS A 263 REMARK 465 SER A 509 REMARK 465 GLY A 510 REMARK 465 GLY A 511 REMARK 465 SER A 512 REMARK 465 GLY A 513 REMARK 465 GLY A 514 REMARK 465 LEU A 515 REMARK 465 MET B 244 REMARK 465 GLY B 245 REMARK 465 SER B 246 REMARK 465 SER B 247 REMARK 465 HIS B 248 REMARK 465 HIS B 249 REMARK 465 HIS B 250 REMARK 465 HIS B 251 REMARK 465 HIS B 252 REMARK 465 HIS B 253 REMARK 465 SER B 254 REMARK 465 SER B 255 REMARK 465 GLY B 256 REMARK 465 LEU B 257 REMARK 465 VAL B 258 REMARK 465 PRO B 259 REMARK 465 ARG B 260 REMARK 465 GLY B 261 REMARK 465 SER B 262 REMARK 465 HIS B 263 REMARK 465 MET B 264 REMARK 465 SER B 509 REMARK 465 GLY B 510 REMARK 465 GLY B 511 REMARK 465 SER B 512 REMARK 465 GLY B 513 REMARK 465 GLY B 514 REMARK 465 LEU B 515 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 302 CD NE CZ NH1 NH2 REMARK 470 ARG A 374 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 469 CG CD CE NZ REMARK 470 THR A 516 OG1 CG2 REMARK 470 ARG A 518 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 520 CG CD CE NZ REMARK 470 GLU B 290 CG CD OE1 OE2 REMARK 470 ARG B 374 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 469 CG CD CE NZ REMARK 470 THR B 516 OG1 CG2 REMARK 470 LYS B 520 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 265 104.66 30.79 REMARK 500 ASN A 298 80.24 -66.34 REMARK 500 ASN A 373 -158.01 -93.77 REMARK 500 GLU A 435 67.63 -100.86 REMARK 500 GLU A 517 -104.29 -6.19 REMARK 500 ASN B 298 80.29 -65.24 REMARK 500 ARG B 374 74.38 -47.95 REMARK 500 MET B 385 -35.02 -38.29 REMARK 500 CYS B 393 57.27 -140.29 REMARK 500 GLU B 435 67.80 -100.74 REMARK 500 GLU B 517 -130.81 37.87 REMARK 500 ARG B 518 41.83 -95.17 REMARK 500 GLN B 527 -81.34 -20.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue O5A A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue O5A B 4000 DBREF 6P9F A 265 508 UNP P51449 RORG_HUMAN 265 508 DBREF 6P9F A 515 528 UNP Q15788 NCOA1_HUMAN 683 696 DBREF 6P9F B 265 508 UNP P51449 RORG_HUMAN 265 508 DBREF 6P9F B 515 528 UNP Q15788 NCOA1_HUMAN 683 696 SEQADV 6P9F MET A 244 UNP P51449 EXPRESSION TAG SEQADV 6P9F GLY A 245 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER A 246 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER A 247 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS A 248 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS A 249 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS A 250 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS A 251 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS A 252 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS A 253 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER A 254 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER A 255 UNP P51449 EXPRESSION TAG SEQADV 6P9F GLY A 256 UNP P51449 EXPRESSION TAG SEQADV 6P9F LEU A 257 UNP P51449 EXPRESSION TAG SEQADV 6P9F VAL A 258 UNP P51449 EXPRESSION TAG SEQADV 6P9F PRO A 259 UNP P51449 EXPRESSION TAG SEQADV 6P9F ARG A 260 UNP P51449 EXPRESSION TAG SEQADV 6P9F GLY A 261 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER A 262 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS A 263 UNP P51449 EXPRESSION TAG SEQADV 6P9F MET A 264 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER A 509 UNP P51449 LINKER SEQADV 6P9F GLY A 510 UNP P51449 LINKER SEQADV 6P9F GLY A 511 UNP P51449 LINKER SEQADV 6P9F SER A 512 UNP P51449 LINKER SEQADV 6P9F GLY A 513 UNP P51449 LINKER SEQADV 6P9F GLY A 514 UNP P51449 LINKER SEQADV 6P9F MET B 244 UNP P51449 EXPRESSION TAG SEQADV 6P9F GLY B 245 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER B 246 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER B 247 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS B 248 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS B 249 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS B 250 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS B 251 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS B 252 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS B 253 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER B 254 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER B 255 UNP P51449 EXPRESSION TAG SEQADV 6P9F GLY B 256 UNP P51449 EXPRESSION TAG SEQADV 6P9F LEU B 257 UNP P51449 EXPRESSION TAG SEQADV 6P9F VAL B 258 UNP P51449 EXPRESSION TAG SEQADV 6P9F PRO B 259 UNP P51449 EXPRESSION TAG SEQADV 6P9F ARG B 260 UNP P51449 EXPRESSION TAG SEQADV 6P9F GLY B 261 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER B 262 UNP P51449 EXPRESSION TAG SEQADV 6P9F HIS B 263 UNP P51449 EXPRESSION TAG SEQADV 6P9F MET B 264 UNP P51449 EXPRESSION TAG SEQADV 6P9F SER B 509 UNP P51449 LINKER SEQADV 6P9F GLY B 510 UNP P51449 LINKER SEQADV 6P9F GLY B 511 UNP P51449 LINKER SEQADV 6P9F SER B 512 UNP P51449 LINKER SEQADV 6P9F GLY B 513 UNP P51449 LINKER SEQADV 6P9F GLY B 514 UNP P51449 LINKER SEQRES 1 A 285 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 285 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 A 285 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 A 285 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 A 285 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 A 285 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 A 285 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 A 285 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 A 285 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 A 285 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 A 285 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 A 285 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 A 285 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 A 285 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 A 285 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 A 285 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 A 285 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 A 285 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 A 285 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 A 285 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 A 285 GLU LEU PHE SER THR SER GLY GLY SER GLY GLY LEU THR SEQRES 22 A 285 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU SEQRES 1 B 285 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 285 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 B 285 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 B 285 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 B 285 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 B 285 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 B 285 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 B 285 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 B 285 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 B 285 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 B 285 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 B 285 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 B 285 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 B 285 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 B 285 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 B 285 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 B 285 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 B 285 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 B 285 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 B 285 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 B 285 GLU LEU PHE SER THR SER GLY GLY SER GLY GLY LEU THR SEQRES 22 B 285 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU HET O5A A4000 42 HET O5A B4000 42 HETNAM O5A TRANS-4-{(3R)-3-[(4-FLUOROPHENYL)SULFONYL]-3-[4-(1,1,1, HETNAM 2 O5A 2,3,3,3-HEPTAFLUOROPROPAN-2-YL)PHENYL]PYRROLIDINE-1- HETNAM 3 O5A CARBONYL}CYCLOHEXANE-1-CARBOXYLIC ACID FORMUL 3 O5A 2(C27 H25 F8 N O5 S) FORMUL 5 HOH *23(H2 O) HELIX 1 AA1 SER A 266 THR A 284 1 19 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 LYS A 311 1 11 HELIX 5 AA5 SER A 312 LEU A 338 1 27 HELIX 6 AA6 CYS A 345 MET A 365 1 21 HELIX 7 AA7 GLY A 384 GLY A 392 5 9 HELIX 8 AA8 CYS A 393 LEU A 410 1 18 HELIX 9 AA9 SER A 413 ILE A 426 1 14 HELIX 10 AB1 GLU A 435 HIS A 458 1 24 HELIX 11 AB2 SER A 461 LEU A 466 1 6 HELIX 12 AB3 PRO A 468 HIS A 490 1 23 HELIX 13 AB4 HIS A 490 PHE A 498 1 9 HELIX 14 AB5 PRO A 499 SER A 507 1 9 HELIX 15 AB6 HIS A 519 GLN A 527 1 9 HELIX 16 AB7 SER B 266 THR B 284 1 19 HELIX 17 AB8 ARG B 288 GLN B 295 1 8 HELIX 18 AB9 ARG B 296 ASN B 298 5 3 HELIX 19 AC1 SER B 301 LYS B 311 1 11 HELIX 20 AC2 SER B 312 LEU B 338 1 27 HELIX 21 AC3 CYS B 345 MET B 365 1 21 HELIX 22 AC4 GLY B 384 GLY B 392 5 9 HELIX 23 AC5 CYS B 393 LEU B 410 1 18 HELIX 24 AC6 SER B 413 ILE B 426 1 14 HELIX 25 AC7 GLU B 435 HIS B 458 1 24 HELIX 26 AC8 SER B 461 LEU B 466 1 6 HELIX 27 AC9 PRO B 468 HIS B 490 1 23 HELIX 28 AD1 HIS B 490 PHE B 498 1 9 HELIX 29 AD2 PRO B 499 SER B 507 1 9 HELIX 30 AD3 HIS B 519 GLU B 528 1 10 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 SITE 1 AC1 20 GLN A 286 LEU A 287 CYS A 320 HIS A 323 SITE 2 AC1 20 LEU A 324 ALA A 327 ARG A 364 MET A 365 SITE 3 AC1 20 ARG A 367 VAL A 376 PHE A 378 PHE A 388 SITE 4 AC1 20 LEU A 391 LEU A 396 ILE A 397 ILE A 400 SITE 5 AC1 20 PHE A 401 HIS A 479 HOH A4101 HOH A4105 SITE 1 AC2 18 GLN B 286 LEU B 287 CYS B 320 HIS B 323 SITE 2 AC2 18 LEU B 324 MET B 358 ARG B 364 MET B 365 SITE 3 AC2 18 ARG B 367 VAL B 376 PHE B 378 PHE B 388 SITE 4 AC2 18 LEU B 396 ILE B 397 ILE B 400 PHE B 401 SITE 5 AC2 18 HIS B 479 HOH B4103 CRYST1 64.128 64.128 159.666 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015594 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015594 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006263 0.00000